Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan.
Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan; Division of Cardiovascular Medicine, Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan.
Diabetes Res Clin Pract. 2018 May;139:122-130. doi: 10.1016/j.diabres.2018.02.009. Epub 2018 Feb 12.
Obesity and ectopic fat accumulation are important conditions of type 2 diabetes mellitus (T2DM). Our aim was to determine whether bioelectrical impedance body composition analysis combined with blood test results could estimate liver ectopic fat accumulation in patients with treatment-naïve T2DM.
Subjects were 119 untreated T2DM patients. Computed tomography scans were performed to calculate the liver to spleen attenuation ratio (L/S ratio) as a measure of liver fat accumulation, with excess liver fat accumulation defined as an L/S ratio <1.0. Elementary body composition was measured by bioelectrical impedance analysis using InBody770.
The Nagelkerke R test showed that the muscle mass/fat mass ratio (muscle/fat ratio) was the most suitable variable among anthropometric factors and body component indexes for estimating liver fat accumulation. The muscle/fat ratio was significantly correlated with the L/S ratio (ρ = 0.4386, P < 0.0001). Multivariable logistic regression analysis showed that the muscle/fat ratio (odds ratio 0.40, 95% confidence interval 0.22-0.73, P < 0.01) and alanine aminotransferase (odds ratio 1.06, 95% confidence interval 1.02-1.10, P < 0.01) were independently and significantly associated with liver fat accumulation. In receiver operating characteristic curve analysis, the cutoff value of the muscle/fat ratio for excess liver fat accumulation was 2.34.
In patients with treatment-naïve T2DM, the muscle/fat ratio and ALT are useful for estimating the presence of excess liver fat accumulation in daily clinical practice.
肥胖和异位脂肪堆积是 2 型糖尿病(T2DM)的重要条件。我们的目的是确定未经治疗的 T2DM 患者的生物电阻抗体成分分析结合血液检查结果是否可以估计肝脏异位脂肪堆积。
研究对象为 119 例未经治疗的 T2DM 患者。通过计算机断层扫描计算肝脏脾脏衰减比(L/S 比)作为肝脏脂肪堆积的指标,将过量的肝脏脂肪堆积定义为 L/S 比<1.0。使用 InBody770 通过生物电阻抗分析测量基本的身体成分。
Nagelkerke R 检验表明,在人体测量因素和身体成分指标中,肌肉质量/脂肪质量比(肌肉/脂肪比)是最适合估计肝脏脂肪堆积的变量。肌肉/脂肪比与 L/S 比显著相关(ρ=0.4386,P<0.0001)。多变量逻辑回归分析表明,肌肉/脂肪比(优势比 0.40,95%置信区间 0.22-0.73,P<0.01)和丙氨酸氨基转移酶(优势比 1.06,95%置信区间 1.02-1.10,P<0.01)与肝脏脂肪堆积独立且显著相关。在接受者操作特征曲线分析中,肌肉/脂肪比的截值用于过量肝脏脂肪堆积为 2.34。
在未经治疗的 T2DM 患者中,肌肉/脂肪比和 ALT 可用于在日常临床实践中估计过量肝脏脂肪堆积的存在。